These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 28780117)

  • 21. Upcoming and future strategies of tick control: a review.
    Ghosh S; Azhahianambi P; Yadav MP
    J Vector Borne Dis; 2007 Jun; 44(2):79-89. PubMed ID: 17722860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunology of the tick-host interaction and the control of ticks and tick-borne diseases.
    Willadsen P; Jongejan F
    Parasitol Today; 1999 Jul; 15(7):258-62. PubMed ID: 10377526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Control of Ixodes ricinus and Dermacentor reticulatus tick infestations in rabbits vaccinated with the Q38 Subolesin/Akirin chimera.
    Contreras M; de la Fuente J
    Vaccine; 2016 Jun; 34(27):3010-3013. PubMed ID: 27154388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Innovative approaches for the control of ticks and tick-borne diseases.
    de la Fuente J; Mazuecos L; Contreras M
    Ticks Tick Borne Dis; 2023 Nov; 14(6):102227. PubMed ID: 37419001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Approaches towards tick and tick-borne diseases control.
    Domingos A; Antunes S; Borges L; Rosário VE
    Rev Soc Bras Med Trop; 2013; 46(3):265-9. PubMed ID: 23559344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-tick and pathogen transmission blocking vaccines.
    van Oosterwijk JG
    Parasite Immunol; 2021 May; 43(5):e12831. PubMed ID: 33704804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunobiology of Acquired Resistance to Ticks.
    Karasuyama H; Miyake K; Yoshikawa S
    Front Immunol; 2020; 11():601504. PubMed ID: 33154758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Control of infestations by Ixodes ricinus tick larvae in rabbits vaccinated with aquaporin recombinant antigens.
    Contreras M; de la Fuente J
    Vaccine; 2017 Mar; 35(9):1323-1328. PubMed ID: 28161419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tick Bioactive Molecules as Novel Therapeutics: Beyond Vaccine Targets.
    Murfin KE; Fikrig E
    Front Cell Infect Microbiol; 2017; 7():222. PubMed ID: 28634573
    [No Abstract]   [Full Text] [Related]  

  • 30. Current status and future prospects of multi-antigen tick vaccine.
    Parthasarathi BC; Kumar B; Ghosh S
    J Vector Borne Dis; 2021; 58(3):183-192. PubMed ID: 35170454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review of reverse vaccinology approaches for the development of vaccines against ticks and tick borne diseases.
    Lew-Tabor AE; Rodriguez Valle M
    Ticks Tick Borne Dis; 2016 Jun; 7(4):573-85. PubMed ID: 26723274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tick hypersensitivity and human tick-borne diseases.
    Ng YQ; Gupte TP; Krause PJ
    Parasite Immunol; 2021 May; 43(5):e12819. PubMed ID: 33428244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospects for vaccination against the ticks of pets and the potential impact on pathogen transmission.
    de la Fuente J; Villar M; Contreras M; Moreno-Cid JA; Merino O; Pérez de la Lastra JM; de la Fuente G; Galindo RC
    Vet Parasitol; 2015 Feb; 208(1-2):26-9. PubMed ID: 25555312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tick-Pathogen Interactions and Vector Competence: Identification of Molecular Drivers for Tick-Borne Diseases.
    de la Fuente J; Antunes S; Bonnet S; Cabezas-Cruz A; Domingos AG; Estrada-Peña A; Johnson N; Kocan KM; Mansfield KL; Nijhof AM; Papa A; Rudenko N; Villar M; Alberdi P; Torina A; Ayllón N; Vancova M; Golovchenko M; Grubhoffer L; Caracappa S; Fooks AR; Gortazar C; Rego ROM
    Front Cell Infect Microbiol; 2017; 7():114. PubMed ID: 28439499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RNA interference screening in ticks for identification of protective antigens.
    de la Fuente J; Almazán C; Blouin EF; Naranjo V; Kocan KM
    Parasitol Res; 2005 Jun; 96(3):137-41. PubMed ID: 15824899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Perspectives of creation of vaccines against tick bite for nonspecific prophylaxis of vector borne diseases].
    Diatlov IA; Biketov SF; Firstova VV
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (4):101-6. PubMed ID: 21913400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Quantum Vaccinomics Approach Based on Protein-Protein Interactions.
    Contreras M; Artigas-Jerónimo S; Pastor Comín JJ; de la Fuente J
    Methods Mol Biol; 2022; 2411():287-305. PubMed ID: 34816412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tick-borne diseases and autoimmunity: A comprehensive review.
    Rodríguez Y; Rojas M; Gershwin ME; Anaya JM
    J Autoimmun; 2018 Mar; 88():21-42. PubMed ID: 29183642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccinomics Approach to Tick Vaccine Development.
    Contreras M; Villar M; Alberdi P; de la Fuente J
    Methods Mol Biol; 2016; 1404():275-286. PubMed ID: 27076305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Communal farmers' perceptions of tick-borne diseases affecting cattle and investigation of tick control methods practiced in Zimbabwe.
    Sungirai M; Moyo DZ; De Clercq P; Madder M
    Ticks Tick Borne Dis; 2016 Feb; 7(1):1-9. PubMed ID: 26234572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.